IO Biotech
IOBT
IOBT
21 hedge funds and large institutions have $41.6M invested in IO Biotech in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
42% less capital invested
Capital invested by funds: $72.2M → $41.6M (-$30.6M)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$271K | |
| 2 | +$119K | |
| 3 | +$111K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$75K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$56.7K |
Top Sellers
| 1 | -$996K | |
| 2 | -$21.5K | |
| 3 | -$10K | |
| 4 |
Morgan Stanley
New York
|
-$5.57K |
| 5 |
Citigroup
New York
|
-$5K |